Related Experiment Videos
Foetal liver infusion in a chronic myeloid leukemia patient with busulphan toxicity
S Sharma1, V Kochupillai, H P Pati
1Department of Laboratory Medicine (Haematology), Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi.
Medical Oncology (Northwood, London, England)
|June 27, 1998
Abstract:
A 36-year-old man suffering from chronic myeloid leukemia (in chronic phase) was initially treated with busulphan. At the end of 6 months of follow-up he developed bone marrow aplasia. He was given single foetal liver infusion therapy. The patient recovered fully from aplasia. He continued in chronic phase for more than 7 years with intermittent busulphan therapy.